Osborne Partners Capital Management’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-44,414
Closed -$2M 193
2017
Q3
$2M Sell
44,414
-11,156
-20% -$595K 0.27% 93
2017
Q2
$3.48M Sell
55,570
-415
-0.7% -$23.9K 0.5% 68
2017
Q1
$3.43M Buy
55,985
+297
+0.5% +$19.9K 0.49% 70
2016
Q4
$3.52M Sell
55,688
-5,820
-9% -$380K 0.52% 67
2016
Q3
$4.1M Sell
61,508
-1,376
-2% -$94.8K 0.61% 61
2016
Q2
$4.78M Sell
62,884
-1,174
-2% -$83.4K 0.71% 52
2016
Q1
$3.91M Buy
64,058
+20,102
+46% +$1.32M 0.57% 62
2015
Q4
$3.42M Sell
43,956
-1,483
-3% -$128K 0.5% 66
2015
Q3
$5M Buy
45,439
+907
+2% +$112K 0.74% 50
2015
Q2
$5.26M Buy
44,532
+30,269
+212% +$3.44M 0.7% 52
2015
Q1
$1.64M Buy
14,263
+7,859
+123% +$855K 0.22% 99
2014
Q4
$665K Buy
+6,404
New +$659K 0.08% 130

Other funds holding EVHC

Osborne Partners Capital Management's EVHC Position: Q4 2017 in Review

Osborne Partners Capital Management sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2017, closing a stake of 44,414 shares — an estimated $2M sold.

Osborne Partners Capital Management first reported a position in EVHC in Q4 2014 and held it in 12 quarters. The position peaked at $5.26M in Q2 2015. 363 funds tracked by Wall St. Rank hold EVHC as of Q4 2017.

  • Osborne Partners Capital Management reported no remaining Envision Healthcare Holdings Inc position as of Q4 2017 after selling out during the quarter.
  • Osborne Partners Capital Management sold 44,414 Envision Healthcare Holdings Inc shares in Q4 2017, an estimated $2M.
  • Osborne Partners Capital Management first reported a position in Envision Healthcare Holdings Inc in Q4 2014 and held it in 12 quarters.
  • Osborne Partners Capital Management's Envision Healthcare Holdings Inc position peaked at $5.26M in Q2 2015.
  • 363 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2017.

Based on Osborne Partners Capital Management's 13F filing for Q4 2017, filed 25 Jan 2018.